신경 진단 시장 규모는 향후 수년간 강력한 성장세를 보일 것으로 예상되며, 2029년에는 연평균 6.8%의 연평균 복합 성장률(CAGR)로 127억 9,000만 달러에 달할 것으로 예측됩니다. 예측 기간 중 비침습적 진단 기술에 대한 수요 증가, 신경질환의 유병률 증가, 의료 인프라에 대한 정부 투자 증가, 인식 개선 및 조기 발견 노력, 맞춤형 의료 접근법 확대 등으로 인해 성장이 예상됩니다. 이 기간의 주요 동향으로는 휴대용 뇌파 장비의 개발, 진단 정확도 향상을 위한 AI의 통합, 뇌 영상 진단을 위한 MRI 기술의 발전, 지속적인 모니터링을 위한 웨어러블의 채택, 신경유전학적 검사의 발전, 개인화된 치료 계획을 위한 실시간 데이터 분석의 활용 등이 있습니다.
신경질환의 유병률 증가는 신경진단제 시장의 확대를 촉진할 것으로 예측됩니다. 뇌, 척수, 신경에 영향을 미치는 신경질환은 다양한 인지장애, 운동장애, 감각장애를 초래합니다. 이러한 장애 증가는 주로 인구 고령화, 환경적 영향, 생활습관의 변화, 유전, 진단 기술의 향상 등의 요인에 기인합니다. 신경 진단 약품은 이러한 질환의 정확한 식별, 평가 및 모니터링에 필수적이며, 정확한 진단, 정보에 입각한 치료법 선택, 신경학적 문제의 효과적인 관리를 돕습니다. 예를 들어 2023년 4월 국립의학도서관은 670만 명의 미국인이 알츠하이머병을 앓고 있으며, 2060년까지 그 수가 1,380만 명으로 증가할 것으로 예상했습니다. 이러한 신경질환의 유병률 증가는 신경진단제 시장을 발전시키고 있습니다.
신경 진단 의약품 시장의 기업은 진단 정확도를 높이고 환자의 예후를 개선하기 위해 첨단 소프트웨어 알고리즘을 포함한 기술 혁신에 집중하고 있습니다. 이러한 고급 알고리즘은 인공지능(AI)과 머신러닝 기술을 사용하여 데이터를 처리하고 분석하여 더 나은 의사결정과 진단을 지원합니다. 예를 들어 2023년 10월 미국 의료기기 제조업체인 Ceribell Inc.는 전기 간질(ESE) 진단에 큰 진전을 보인 ClarityPro AI 알고리즘을 발표했습니다. Ceribell 뇌파계 시스템과 통합된 이 첨단 소프트웨어는 머신러닝을 통해 뇌파 파형을 분석하여 발작이 의심되는 경우 실시간으로 경고를 보내며, ClarityPro는 FDA의 승인을 받은 최초의 독립형 진단용 급성기 의료기기로서 뇌 활동을 지속적으로 모니터링하고 지속적으로 뇌 활동을 모니터링하고 실용적인 인사이트를 제공함으로써 임상의가 보다 신속하고 정보에 입각한 치료 결정을 내릴 수 있도록 돕습니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 동향과 전략
제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나바이러스의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계의 신경 진단약 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 용도 산업의 분석
- 세계의 신경 진단약 시장 : 성장률 분석
- 세계의 신경 진단약 시장 실적 : 규모와 성장, 2019-2024
- 세계의 신경 진단약 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계 신경 진단약 TAM(Total Addressable Market)
제6장 시장 세분화
- 세계의 신경 진단약 시장 : 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 진단 및 영상 솔루션
- 체외진단
- 세계의 신경 진단약 시장 : 기술별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 신경 영상 기술
- 컴퓨터 단층촬영(CT)
- 자기공명영상(MRI)
- 핵의학 영상 진단(PET, SPECT)
- 근적외선 분광 이미징(NIRS)
- 뇌파 검사(EEG)
- 자기 뇌파 검사(MEG)
- VBM(Voxel Based Morphometry)
- 뉴로인포매틱스
- 세계의 신경 진단약 시장 : 상태별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 간질
- 알츠하이머병
- 파킨슨병
- 뇌졸중
- 관절 건강
- 기타 조건
- 세계의 신경 진단약 시장 : 최종 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 병원과 진료소
- 진단 검사실
- 영상 센터
- 기타 용도
- 세계의 신경 진단약 시장, 진단 및 영상 진단 솔루션의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- MRI(자기공명영상) 시스템
- CT(컴퓨터 단층촬영) 스캐너
- EEG(뇌파) 시스템
- EMG(근전도) 시스템
- MEG(뇌자도) 시스템
- PET(양전자 방출 단층촬영) 스캐너
- SPECT(단일 광자 방출 컴퓨터 단층촬영) 스캐너
- 기능적 MRI(fMRI) 시스템
- 두개내압 모니터
- 세계의 신경 진단약 시장, 체외진단 약의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 혈액 기반 진단
- 뇌척수액(CSF) 분석
- 유전자 검사와 바이오마커
- 신경 화학 진단
- POC(Point of Care) 신경 진단약
- 신경변성질환의 진단 키트
제7장 지역별·국가별 분석
- 세계의 신경 진단약 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 신경 진단약 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 신경 진단약 시장 : 경쟁 구도
- 신경 진단약 시장 : 기업 개요
- Nihon Kohden Corporation Overview, Products and Services, Strategy and Financial Analysis
- Cephalon LLC Overview, Products and Services, Strategy and Financial Analysis
- Stratus Neuro LLC Overview, Products and Services, Strategy and Financial Analysis
- Cadwell Industries Inc. Overview, Products and Services, Strategy and Financial Analysis
- Compumedics Limited Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 대기업과 혁신적 기업
- Ceribell Inc.
- CND Life Sciences Inc.
- Lifelines Neuro Inc.
- ANT Neuro B.V.
- Neurovative Diagnostics LLC
- Firefly Neuroscience Inc
- IntraNerve Neuroscience Inc
- NeuroDiagnostics Laboratories LLC
- Advanced Brain Monitoring Inc
- Spes Medica S.r.l.
- BioSignal Group Inc
- Combinostics Inc.
- Deymed Diagnostic LLC
- NeuLine Health Inc.
- Ridge Diagnostics Inc.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 합병과 인수
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
- 신경 진단약 시장 2029 : 새로운 기회를 제공하는 국가
- 신경 진단약 시장 2029 : 새로운 기회를 제공하는 부문
- 신경 진단약 시장 2029 : 성장 전략
제36장 부록
KSA
Neurodiagnostics is a medical field focused on diagnosing and monitoring disorders of the nervous system, which includes the brain, spinal cord, and peripheral nerves. It utilizes advanced technologies and tests to evaluate neurological function, detect abnormalities, and help diagnose conditions such as epilepsy, stroke, multiple sclerosis, neuropathies, and other neurological diseases.
The primary types of neurodiagnostic tools are diagnostic and imaging solutions, as well as in-vitro diagnostics. Diagnostic and imaging solutions include medical technologies and services designed to detect health conditions through various imaging techniques and diagnostic tools. Key technologies in this area include neuroimaging, computed tomography (CT), magnetic resonance imaging (MRI), nuclear medicine imaging (PET, SPECT), near-infrared spectroscopic imaging (NIRS), electroencephalography (EEG), magnetoencephalography (MEG), voxel-based morphometry (VBM), and neuroinformatics. These diagnostic tools are vital for treating conditions such as epilepsy, Alzheimer's disease, Parkinson's disease, stroke, joint health problems, and more, and are used in hospitals, clinics, diagnostic laboratories, imaging centers, and other healthcare settings.
The neurodiagnostic market research report is one of a series of new reports from The Business Research Company that provides neurodiagnostic market statistics, including the neurodiagnostic industry's global market size, regional shares, competitors with a neurodiagnostic market share, detailed neurodiagnostic market segments, market trends and opportunities, and any further data you may need to thrive in the neurodiagnostic industry. This neurodiagnostic market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The neurodiagnostics market size has grown strongly in recent years. It will grow from $9.17 billion in 2024 to $9.82 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth during the historic period can be attributed to factors such as the rising prevalence of neurological disorders, increased adoption of advanced imaging technologies, the growing geriatric population, heightened awareness of early disease diagnosis, expanding healthcare infrastructure, and increased investments in neuroscience research and development.
The neurodiagnostics market size is expected to see strong growth in the next few years. It will grow to $12.79 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. For the forecast period, growth is expected due to the rising demand for non-invasive diagnostic techniques, the growing prevalence of neurological disorders, higher government investments in healthcare infrastructure, increased awareness and early detection initiatives, and the expansion of personalized medicine approaches. Key trends during this period include the development of portable EEG devices, integration of AI for improved diagnostic accuracy, advancements in MRI technologies for brain imaging, the adoption of wearables for continuous monitoring, advancements in neurogenetic testing, and the use of real-time data analytics for personalized treatment plans.
The growing prevalence of neurological disorders is expected to propel the expansion of the neurodiagnostics market. Neurological disorders, which affect the brain, spinal cord, or nerves, result in various cognitive, motor, and sensory impairments. The increase in these disorders is primarily attributed to factors such as aging populations, environmental influences, lifestyle changes, genetics, and improvements in diagnostic techniques. Neurodiagnostics are crucial for the accurate identification, assessment, and monitoring of these conditions, helping ensure precise diagnoses, informed treatment choices, and effective management of neurological issues. For instance, in April 2023, the National Library of Medicine reported that 6.7 million Americans were living with Alzheimer's disease, a number expected to rise to 13.8 million by 2060. This growing prevalence of neurological conditions is driving the neurodiagnostics market forward.
Companies in the neurodiagnostics market are focusing on technological innovations, including advanced software algorithms, to enhance diagnostic accuracy and improve patient outcomes. These sophisticated algorithms use artificial intelligence (AI) and machine learning techniques to process and analyze data, supporting better decision-making and diagnostics. For example, in October 2023, Ceribell Inc., a US-based medical equipment company, launched the ClarityPro AI algorithm, which represents a significant advancement in diagnosing electrographic status epilepticus (ESE). This advanced software, integrated with the Ceribell EEG system, uses machine learning to analyze EEG waveforms and provide real-time alerts for suspected seizures. ClarityPro is the first acute care device to receive FDA clearance for standalone diagnosis, helping clinicians make quicker, more informed treatment decisions by continuously monitoring brain activity and providing actionable insights.
In July 2022, ArchiMed SAS, a France-based investment firm focused on the healthcare sector, acquired Natus Medical Incorporated for $1.1 billion. This acquisition enhances ArchiMed's position in the neurodiagnostics space by leveraging Natus Medical's expertise in developing medical devices for screening, diagnosing, and treating neurological disorders.
Major players in the neurodiagnostics market are Nihon Kohden Corporation, Cephalon LLC, Stratus Neuro LLC, Cadwell Industries Inc., Compumedics Limited, Ceribell Inc., CND Life Sciences Inc., Lifelines Neuro Inc., ANT Neuro B.V., Neurovative Diagnostics LLC, Firefly Neuroscience Inc, IntraNerve Neuroscience Inc, NeuroDiagnostics Laboratories LLC, Advanced Brain Monitoring Inc, Spes Medica S.r.l., BioSignal Group Inc, Combinostics Inc., Deymed Diagnostic LLC, NeuLine Health Inc., Ridge Diagnostics Inc., Beacon Biosignals Inc., and Intch Inc.
North America was the largest region in the neurodiagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in neurodiagnostics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the neurodiagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The neurodiagnostics market includes revenues earned by entities by providing services such as electroencephalography (EEG), positron emission tomography (PET), cerebrospinal fluid (CSF) analysis, and sleep apnea diagnosis. The market value includes the value of related goods sold by the service provider or included within the service offering. The neurodiagnostic market consists of sales of transcranial magnetic stimulation (TMS) devices, magnetoencephalography (MEG) systems, polysomnography (PSG) devices, and biosensors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Neurodiagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on neurodiagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for neurodiagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The neurodiagnostics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: Diagnostic And Imaging Solutions; In-Vitro Diagnostics
- 2) By Technology: Neuroimaging Technologies; Computed Tomography (CT); Magnetic Resonance Imaging (MRI); Nuclear Medicine Imaging (PET, SPECT); Near Infrared Spectroscopic Imaging (NIRS); Electro-Encephalography (EEG); Magneto-Encephalography (MEG); Voxel Based Morphometry (VBM); Neuroinformatics
- 3) By Condition: Epilepsy; Alzheimer's Disease; Parkinson's Disease; Stroke; Joint Health; Other Conditions
- 4) By End Use : Hospitals And Clinics; Diagnostic Laboratories; Imaging Centers; Other End Uses
- Subsegments:
- 1) By Diagnostic And Imaging Solutions: MRI (Magnetic Resonance Imaging) Systems; CT (Computed Tomography) Scanners; EEG (Electroencephalogram) Systems; EMG (Electromyography) Systems; MEG (Magnetoencephalography) Systems; PET (Positron Emission Tomography) Scanners; SPECT (Single Photon Emission Computed Tomography) Scanners; Functional MRI (fMRI) Systems; Intracranial Pressure Monitors
- 2) By In-Vitro Diagnostics: Blood-Based Diagnostics; Cerebrospinal Fluid (Csf) Analysis; Genetic Testing And Biomarkers; Neurochemical Diagnostics; Point-Of-Care Neurodiagnostics; Diagnostic Kits For Neurodegenerative Disorders
- Companies Mentioned:Nihon Kohden Corporation; Cephalon LLC; Stratus Neuro LLC; Cadwell Industries Inc.; Compumedics Limited
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Neurodiagnostics Market Characteristics
3. Neurodiagnostics Market Trends And Strategies
4. Neurodiagnostics Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Neurodiagnostics Growth Analysis And Strategic Analysis Framework
- 5.1. Global Neurodiagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Neurodiagnostics Market Growth Rate Analysis
- 5.4. Global Neurodiagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Neurodiagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Neurodiagnostics Total Addressable Market (TAM)
6. Neurodiagnostics Market Segmentation
- 6.1. Global Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Diagnostic And Imaging Solutions
- In-Vitro Diagnostics
- 6.2. Global Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Neuroimaging Technologies
- Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- Nuclear Medicine Imaging (PET, SPECT)
- Near Infrared Spectroscopic Imaging (NIRS)
- Electro-Encephalography (EEG)
- Magneto-Encephalography (MEG)
- Voxel Based Morphometry (VBM)
- Neuroinformatics
- 6.3. Global Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Epilepsy
- Alzheimer's Disease
- Parkinson's Disease
- Stroke
- Joint Health
- Other Conditions
- 6.4. Global Neurodiagnostics Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals And Clinics
- Diagnostic Laboratories
- Imaging Centers
- Other End Uses
- 6.5. Global Neurodiagnostics Market, Sub-Segmentation Of Diagnostic And Imaging Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- MRI (Magnetic Resonance Imaging) Systems
- CT (Computed Tomography) Scanners
- EEG (Electroencephalogram) Systems
- EMG (Electromyography) Systems
- MEG (Magnetoencephalography) Systems
- PET (Positron Emission Tomography) Scanners
- SPECT (Single Photon Emission Computed Tomography) Scanners
- Functional MRI (fMRI) Systems
- Intracranial Pressure Monitors
- 6.6. Global Neurodiagnostics Market, Sub-Segmentation Of In-Vitro Diagnostics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Blood-Based Diagnostics
- Cerebrospinal Fluid (Csf) Analysis
- Genetic Testing And Biomarkers
- Neurochemical Diagnostics
- Point-Of-Care Neurodiagnostics
- Diagnostic Kits For Neurodegenerative Disorders
7. Neurodiagnostics Market Regional And Country Analysis
- 7.1. Global Neurodiagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Neurodiagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Neurodiagnostics Market
- 8.1. Asia-Pacific Neurodiagnostics Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Neurodiagnostics Market
- 9.1. China Neurodiagnostics Market Overview
- 9.2. China Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Neurodiagnostics Market
- 10.1. India Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Neurodiagnostics Market
- 11.1. Japan Neurodiagnostics Market Overview
- 11.2. Japan Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Neurodiagnostics Market
- 12.1. Australia Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Neurodiagnostics Market
- 13.1. Indonesia Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Neurodiagnostics Market
- 14.1. South Korea Neurodiagnostics Market Overview
- 14.2. South Korea Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Neurodiagnostics Market
- 15.1. Western Europe Neurodiagnostics Market Overview
- 15.2. Western Europe Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Neurodiagnostics Market
- 16.1. UK Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Neurodiagnostics Market
- 17.1. Germany Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Neurodiagnostics Market
- 18.1. France Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Neurodiagnostics Market
- 19.1. Italy Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Neurodiagnostics Market
- 20.1. Spain Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Neurodiagnostics Market
- 21.1. Eastern Europe Neurodiagnostics Market Overview
- 21.2. Eastern Europe Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Neurodiagnostics Market
- 22.1. Russia Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Neurodiagnostics Market
- 23.1. North America Neurodiagnostics Market Overview
- 23.2. North America Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Neurodiagnostics Market
- 24.1. USA Neurodiagnostics Market Overview
- 24.2. USA Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Neurodiagnostics Market
- 25.1. Canada Neurodiagnostics Market Overview
- 25.2. Canada Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Neurodiagnostics Market
- 26.1. South America Neurodiagnostics Market Overview
- 26.2. South America Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Neurodiagnostics Market
- 27.1. Brazil Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Neurodiagnostics Market
- 28.1. Middle East Neurodiagnostics Market Overview
- 28.2. Middle East Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Neurodiagnostics Market
- 29.1. Africa Neurodiagnostics Market Overview
- 29.2. Africa Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Neurodiagnostics Market Competitive Landscape And Company Profiles
- 30.1. Neurodiagnostics Market Competitive Landscape
- 30.2. Neurodiagnostics Market Company Profiles
- 30.2.1. Nihon Kohden Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Cephalon LLC Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Stratus Neuro LLC Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Cadwell Industries Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Compumedics Limited Overview, Products and Services, Strategy and Financial Analysis
31. Neurodiagnostics Market Other Major And Innovative Companies
- 31.1. Ceribell Inc.
- 31.2. CND Life Sciences Inc.
- 31.3. Lifelines Neuro Inc.
- 31.4. ANT Neuro B.V.
- 31.5. Neurovative Diagnostics LLC
- 31.6. Firefly Neuroscience Inc
- 31.7. IntraNerve Neuroscience Inc
- 31.8. NeuroDiagnostics Laboratories LLC
- 31.9. Advanced Brain Monitoring Inc
- 31.10. Spes Medica S.r.l.
- 31.11. BioSignal Group Inc
- 31.12. Combinostics Inc.
- 31.13. Deymed Diagnostic LLC
- 31.14. NeuLine Health Inc.
- 31.15. Ridge Diagnostics Inc.
32. Global Neurodiagnostics Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Neurodiagnostics Market
34. Recent Developments In The Neurodiagnostics Market
35. Neurodiagnostics Market High Potential Countries, Segments and Strategies
- 35.1 Neurodiagnostics Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Neurodiagnostics Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Neurodiagnostics Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
